Company Filing History:
Years Active: 1999-2019
Title: Innovations of Gurpreet Singh in Immunotherapy
Introduction
Gurpreet Singh is an accomplished inventor based in Houston, TX, known for his significant contributions to the field of immunotherapy. With a total of four patents to his name, Singh has focused on developing innovative methods to treat various types of cancers.
Latest Patents
Singh's latest patents include immunogenic compositions comprising progastrin and their uses. These inventions are directed towards immunotherapeutic methods aimed at treating tumors or cancers that produce progastrin ectopically or rely on progastrin for their growth. The disclosed immunogenic compositions consist of agents that target progastrin, agents that target the progastrin receptor, annexin II, or both. Such compositions may be administered in conjunction with chemotherapy or to individuals who have previously undergone chemotherapy or radiation therapy. The cancers that can be treated using these compositions include, but are not limited to, colon cancer, breast cancer, lung cancer, and pancreatic cancer.
Career Highlights
Throughout his career, Gurpreet Singh has worked with notable organizations such as Zonagen, Inc. and the University of Texas System. His experience in these institutions has contributed to his expertise in the field of immunotherapy and cancer treatment.
Collaborations
Singh has collaborated with various professionals in his field, including Pomila Singh and Joseph S. Podolski. These collaborations have further enhanced his research and development efforts in immunotherapeutic methods.
Conclusion
Gurpreet Singh's innovative work in immunotherapy showcases his dedication to advancing cancer treatment. His patents reflect a commitment to improving patient outcomes through targeted therapies.